Skip to main content
OpenTrials
Completed

NCT Number: NCT03177174

Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma

This study was to evaluate the efficacy ,toxic reaction and safety of different chemotherapy combined with radiotherapy on patients with locally advanced nasopharyngeal carcinoma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chinese PLA general hospital

Beijing, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients > 18, <70 years old, with locally advanced nasopharyngeal carcinoma.

Exclusion criteria

  • patients who had accepted radiotherapy before patients with any ather types of cancer

Treatment and study plan

Cisplatin

Drug

radiotherapy combined with Chemotherapy Drugs, Cancer

docetaxel

Drug

Docetaxel

Primary outcomes

  1. changes in toxic reaction

    Time frame: 5 years

    incidence rate of the toxic reaction between three groups

Secondary outcomes

  1. over survival

    Time frame: 5 years

    differences of over survival rate between three groups

Sponsors and collaborators

Lead sponsor

Luo yanrong

Other

Registry information

Official study title

the General Hospital of PLA

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jun 6, 2017
Registry last updated
Feb 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.